PMLiVE Following behind is necitumumab, in phase III trials alongside gemcitabine and cisplatin for first-line treatment of squamous non-small cell lung cancer (NSCLC). The company's phase II portfolio features 16 programmes, including two c-Met-targetting ... and more »
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
Windsor Star (blog) News broke a month ago that diluted doses of two chemotherapy drugs, cyclophosphamide and gemcitabine , mixed and supplied by Marchese, had been administered to more than 1,200 cancer patients at four Ontario hospitals and one in New Brunswick. and more »
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
7thSpace Interactive (press release) Doxorubicin-based chemotherapy was given in 15 cases (60%), gemcitabine -based therapy in 5 cases (20%), and paclitaxel in 5 cases (20%). First-line chemotherapy was delivered in 18 cases (72%). No patients had a complete or partial response, ...
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
Arizona Republic ... Dr. Daniel Von Hoff, TGen physician-in-chief, presented study results at a San Francisco cancer symposium, showing that the drug Abraxane (nab-paclitaxel) when combined with gemcitabine , significantly extended the survival of pancreatic cancer ...
Toronto Star The Mississauga company won a group contract from Baxter to supply four hospitals in Ontario and one in New Brunswick with pre-mixed solutions of cyclophosphamide and gemcitabine — drugs often used to treat cancers of the breast, lung and bladder.
Seeking Alpha And the other study being a very interested study in pancreatic cancer, and just to note that these are first line patients, but they are actually getting standard of care, currently which is about the change is gemcitabine for first line patients in ... and more »
